Cpwm, LLC Gilead Sciences, Inc. Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cpwm, LLC holds 21,787 shares of GILD stock, worth $2.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

21,787

Previous 36,306 39.99%

Holding current value

$2.7 Million

Previous $2.24 Million 40.11%

% of portfolio

0.13%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $864,461 - $987,437	-14,519 Reduced 39.99%	21,787 $1.34 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $801,269 - $902,468	13,882 Added 61.91%	36,306 $2.24 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $510,622 - $639,865	-8,816 Reduced 28.22%	22,424 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $417,173 - $450,083	6,163 Added 24.58%	31,240 $2.18 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $1,078 - $1,178	17 Added 0.07%	25,077 $1.73 Million

Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $13,260 - $15,129	-221 Reduced 0.87%	25,060 $1.62 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $20,507 - $23,367	362 Added 1.45%	25,281 $1.47 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $16,580 - $20,847	-267 Reduced 1.06%	24,919 $1.58 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $392,010 - $455,196	-5,419 Reduced 17.71%	25,186 $1.94 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $34,884 - $44,682	557 Added 1.85%	30,605 $2.29 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $61 - $67	-1 Reduced -0.0%	30,048 $1.95 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $37,068 - $40,917	593 Added 2.01%	30,049 $1.9 Million
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $1 Million - $1.13 Million	16,219 Added 122.53%	29,456 $1.99 Million
Q1 2019 May 06, 2019	BUY	$62.53 - $70.05 $3,251 - $3,642	52 Added 0.39%	13,237 $861,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $12,229 - $15,958	-202 Reduced 1.51%	13,185 $825,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $204,858 - $226,816	-2,874 Reduced 17.67%	13,387 $1.03 Million
Q2 2018 Dec 21, 2018	BUY	$64.88 - $75.68 $764,026 - $891,207	11,776 Added 262.56%	16,261 $1.15 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $721,919 - $842,091	-11,127 Reduced 71.27%	4,485 $318,000
Q1 2018 Dec 21, 2018	BUY	$72.84 - $88.8 $921,935 - $1.12 Million	12,657 Added 428.32%	15,612 $1.18 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $122,953 - $149,894	-1,688 Reduced 36.36%	2,955 $223,000
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $2,276 - $2,672	32 Added 0.69%	4,643 $333,000
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $120,279 - $142,563	-1,668 Reduced 26.56%	4,611 $374,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,279	6,279 $444,000

Others Institutions Holding GILD

# of Institutions

2,369

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account